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ABSTRACT The boronic functionalities on the outer surface of the Gd(III) bis(m-boroxyphenylamide)DTPA complex (Gd(III)L)
enable it to bind to fructosamine residues of oxygenated glycated human adult hemoglobin. The formation of the macro-
molecular adduct can be assessed by NMR spectroscopy via observation of the enhancement of the solvent water proton
relaxation rate. Unexpectedly, a strong binding interaction was also observed for the oxygenated unglycated human adult
hemoglobin, eventually displaying a much higher relaxation enhancement. From relaxation rate measurements it was found
that two Gd(III)L complexes interact with one hemoglobin tetramer (KD  1.0  10
5 M and 4.6  104 M, respectively),
whereas no interaction has been observed with monomeric hemoproteins. A markedly higher affinity of the Gd(III)L complex
has been observed for oxygenated and aquo-met human adult hemoglobin derivatives with respect to the corresponding
deoxy derivative. Upon binding, a net change in the quaternary structure of hemoglobin has been assessed by monitoring the
changes in the high-resolution 1H-NMR spectrum of the protein as well as in the Soret absorption band. On the basis of these
observations and the 11B NMR results obtained with the diamagnetic La(III)L complex, we suggest that the interaction
between the lanthanide complex and deoxygenated, oxygenated, and aquo-met derivatives of human adult hemoglobin takes
place at the 2,3-diphosphoglycerate (DPG) binding site, through the formation of N3B coordinative bonds at His143 and
His2 residues of different -chains. The stronger binding to the oxygenated form is then responsible for a shift of the allosteric
equilibrium toward the high-affinity R-state. Accordingly, Gd(III)L affinity for oxygenated human fetal hemoglobin (lacking
His143) is significantly lower than that observed for the unglycated human adult tetramer.
INTRODUCTION
In recent years, gadolinium (III) complexes have received
increasing attention, in view of their ability to enhance
water proton relaxation rates of their aqueous solutions.
This property has been widely exploited in the design of
contrast agents for magnetic resonance imaging (MRI)
(Lauffer, 1987; Tweedle, 1989; Koenig and Brown, 1990).
Further developments in this field are expected to be
aimed at the search for an improved capability of the metal
complexes to act as reporters of the molecular environment.
This means that the relaxation rate of water protons in a
given tissue may become dependent on the interactions that
the metal complex is able to set up with other substrates.
This goal may be pursued through the introduction of suit-
able functionalizations on the outer surface of the ligand to
enable the complex to recognize specific target molecules.
A simple way to introduce the desired functionality is
provided by the formation of bisamide derivatives of dieth-
ylenetriaminepentaacetic acid (DTPA) according to Chart 1
(Quay, 1987; Konings et al., 1990; Aime et al., 1993a,b,
1994, 1995; Rizkalla et al., 1993; Geraldes et al., 1993,
1995). A bisamide DTPA ligand from DTPA anhydride and
m-aminophenylboronic acid, namely bis(m-boroxyphenyl-
amide)DTPA (hereafter L), was first reported in 1993
(Aime et al., 1993b). Its Gd(III) complex (Chart 2) shows a
relatively high thermodynamic stability (Kf  2.0  10
16
M1), good relaxivity at 25.0°C (R1p 4.6 mM
1 s1) and,
through the boronic functionalities, the peculiar capability
to bind sugars containing the syn-diol moiety (Aime et al.,
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1993a). (Millimolar relaxivity, R1p, is the paramagnetic
contribution to the overall solvent water proton magnetic
relaxation rate in the presence of a 1 mM concentration of
the paramagnetic species. R1p is given by R1p  (T1
obs)1 
(T1
dia)1, where (T1
dia)1 is the water proton relaxation rate
of a solution containing an analogous diamagnetic complex,
which in a dilute solution is equal to that of pure water. At
25.0°C and 20 MHz, (T1
dia)1  0.38 s1.) This property
was exploited to determine the extent of glycation of human
serum albumin, the binding of the bis(m-boroxyphenylam-
ide)diethylenetriaminepentaacetic acid gadolinium(III)
(Gd(III)L) complex to the macromolecule, inducing a sig-
nificant increase in relaxivity as a consequence of the
lengthening of the molecular reorientational time (R).
A straighforward extension of this study led us to con-
sider glycated Hb as a target for Gd(III)L for the important
implications this species has in the control of sugar levels in
diabetic patients.
Hb glycation occurs at the N-terminal Val1 residue of
both -chains through the formation of a Schiff base that
successively undergoes the Amadori rearrangement by hy-
drogen transposition to saturate the NAC double bond and
to form a ketonic group at the carbon adjacent to that moiety
(fructosamine) (Baker et al., 1991). Our attempt to extend
the relaxometric assay to human hemoglobin (Hb) has un-
expectedly shown that a strong interaction with the protein
also occurs in the absence of protein glycation. In this paper,
the interaction of Hb with Gd(III)L has been assessed either
by a ligand-binding assay based on the water proton relax-
ation enhancement analysis (Eisinger et al., 1961; Aime et
al., 1996a) or by high-resolution NMR spectroscopy. These
results allow us to recognize that this complex may act as an
allosteric effector for human hemoglobin by stabilizing its
high-affinity R state. Stabilization of the R state is rather
uncommon. There are few other molecules that can do this
through the link of -chains together, thus yielding a con-
straint which is at minimum when the tetrameric protein is
in the high-affinity R state (Abraham et al., 1995; Boyiri et
al., 1995).
MATERIALS AND METHODS
Hemoglobins and chemicals
Oxygenated human adult Hb (HbA) was obtained from freshly drawn
venous blood samples (Antonini and Brunori, 1971). Oxygenated human fetal
Hb (HbF) was obtained from umbilical cord blood samples (Antonini and
Brunori, 1971), and the HbF-to-total Hb ratio was determined by ion-exchange
high-performance liquid chromatography. Oxygenated HbA and HbF concen-
tration was determined using the extinction coefficients of 14.4 mM1 cm1
at 541 nm and 14.6 mM1 cm1 at 542 nm, respectively (pH 7.0) (Zijlstra et
al., 1991). Although extinction coefficients are given per heme, Hb concen-
trations reported in the text refer to the tetramer content.
Ferric (aquo-met) HbA was prepared from oxygenated Hb by treatment
with sodium nitrite (Antonini and Brunori, 1971). Ferric (aquo-met) HbA
concentration was determined on the basis of the extinction coefficient 9.07
mM1 cm1 at 500 nm at pH 7.3 (Zijlstra et al., 1991).
Deoxygenated HbA was obtained from oxygenated HbA by bubbling
water-saturated N2 through the sample.
Oxygenated unglycated human adult hemoglobin (HbA0) and oxygen-
ated glycated human adult hemoglobin (HbA1c) were obtained from chro-
matographic separation of HbA by means of aminophenylboronic acid
affinity gel chromatography (GHb-PBA), where agarose-bound boronate
groups reversibly bind glucose as syn-diols (Wettre et al., 1993). By this
procedure HbA0 was eluted first by using 50 mM ammonia buffer at pH
9.25 as the eluent. HbA1c was then eluted using 0.1 M sorbitol in the same
buffer, and the protein was recovered by centrifugal ultrafiltration to wash
out the excess of sorbitol with phosphate-buffered saline (PBS) (3 mM
phosphate buffer, 0.150 M NaCl). HbA was obtained from blood samples
freshly drawn from diabetic patients.
Ferric horse myoglobin and ferric horse heart cytochrome c were
obtained from Sigma Chemical Co. (St. Louis, MO) and used without
further purification.
Bis(m-boroxyphenylamide)DTPA and its La(III) and Gd(III) complexes
were prepared according to a previously reported procedure (Aime et al.,
1993a).
All chemicals were of analytical grade and used without further puri-
fication.
Values of P50 and n for oxygen binding to HbA (50–100 M as
tetramer), in the absence and presence of 1.0  104 M Gd(III)L, were
determined at pH 7.2 in PBS and 25.0°C from absorbance changes accom-
panying oxy-HbA formation by the tonometric method (Antonini and
Brunori, 1971).
Oxygenated and deoxygenated Hb samples contained less than 1% of
ferric (aquo-met)Hb, under all of the experimental conditions.
Values of the sedimentation coefficient of the oxygenated, deoxygen-
ated, and ferric (aquo-met) HbA and HbF, in the absence and presence of
Gd(III)L (ranging between 0.1 and 1.0 mM), were determined with a
SPINCO model E analytical ultracentrifuge at 52,000 rpm (Ascenzi et al.,
1993).
NMR measurements
Water proton T1 measurements of ferric (aquo-met) Hb, oxy-Hb, and
deoxy-Hb, in the absence and in the presence of 1.0  104 M Gd(III)L,
were obtained between pH 7.2 and pH 10.0 on a Stelar SpinMaster
Spectrometer (Stelar, Mede (PV), Italy) operating at 20 MHz, by means of
the Inversion-Recovery technique (16 experiments, four scans). Magneti-
zation values were obtained by averaging the first 128 data points of the
Free Induction Decay (FID). A phase cycle (x, x, x, x) was applied
on the 90° observation pulse to cut off the y-scale receiver offset. A typical
90° pulse width was 3.5 s. The tau values were linearly increased from a
starting value corresponding to one-seventh of the estimated null point
(0.693  T1), so that the null point occurs at the middle of the inversion
recovery curve (seventh experiment). In the 16th experiment the FID is
acquired after a single 90° pulse, to get theM value (Bertini and Luchinat,
1986). The reproducibility in T1 measurements was 0.5%. The temper-
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ature was controlled with a Stelar VTC-91 air flow heater, equipped with a
copper-constantan thermocouple; the actual temperature in the probe head was
measured with a Fluke 52 k/j digital thermometer, with an uncertainty of
0.3°C.
R1p values (see the description of millimolar relaxivity, R1p, in the
Introduction) have been determined by subtracting from the observed
relaxation rate (R1
obs) in the presence of the Gd(III)L complex the blank
relaxivity value (R1
dia) measured for solutions containing the same hemo-
protein in the same concentration without the gadolinium complex. Al-
though symbols with the dia superscript usually refer to diamagnetic
systems, this is not the case in the present study, where both dia- and
paramagnetic protein contributions have to be subtracted to determine the
contribution of the Gd(III)L complex alone. The R1
dia values, determined at
298 K for a 1.0 mM protein solution, are as follows: 0.61 s1 for
oxy-HbA0, 0.77 s
1 for deoxy-HbA0, 1.4 s
1 for ferric (aquo-met) HbA,
0.59 s1 for oxy-HbF, and 0.54 s1 for oxy-HbA1c.
High-resolution 1H NMR spectra were obtained in 90% H2O, 10% D2O
PBS, at 400 MHz proton Larmor frequency on a Bruker AVANCE 400
spectrometer, at 29°C and pH 7.2. The intense water signal has been sup-
pressed using the WATERGATE 3-9-19 pulse sequence (Piotto et al., 1992).
11B NMR spectra were obtained in D2O, at 25.0°C and between pD 5.5
and 11.0, on a JEOL EX-400 Fourier transform NMR spectrometer, oper-
ating at a 11B Larmor frequency of 128.3 MHz, equipped with a built-in
temperature controller.
The Proton Relaxation Enhancement method
The established theory (Dwek, 1973; Bertini and Luchinat, 1986; Koenig
and Brown, 1990; Banci et al., 1991) describes R1
obs as the sum of three
terms:
R1
obs R1p
is  R1p
os  R1
dia (1)
where R1p
is is the contribution from the exchange of water molecules in the
inner coordination sphere of the paramagnetic metal ion to the bulk water;
R1p
os is the paramagnetic contribution arising from water molecules diffus-
ing in the proximity of the metal ion; and R1
dia represents the solvent
relaxation rate in the absence of the paramagnetic complex.
The R1p
is contribution is determined by the value of the relaxation time
of the coordinated water molecule (T1M) and by the exchange lifetime M:
R1p
is  M	/55.56
T1M M (2)
where [M] is the molar concentration of the paramagnetic species. T1M
depends on the strength of the dipolar interaction (K) between the protons
of the coordinated water and the unpaired electrons modulated by a
function of its correlation time f(c):
1/T1M Kf
c (3)
The correlation time c is determined by
c
1 R
1 M
1 S
1 (4)
where R is the molecular reorientational correlation time and S is the
electronic relaxation time. The latter parameter is field-dependent, and its
value increases with the observation frequency; at the operating frequency
(20 MHz) it is long enough to be negligible in Eq. 4. Thus the observed
relaxation rate depends basically on the reorientational correlation time R
and consequently on the molecular size of the system containing the
paramagnetic metal. The interaction of the metal chelate with the large
protein will then lead to an enhancement of the relaxation rate.
The binding isotherm obtained by plotting the relaxation enhancement
factor * versus the concentration of protein may be analyzed by means of
the well-established Proton Relaxation Enhancement (PRE) procedure
(Eisinger et al., 1961; Mildvan and Cohn, 1963). The observed relaxation
enhancement (*) is the result of the higher relaxation rate of the solutions
containing the slowly tumbling Gd(III)L-Hb adduct:
* R*1p/R1p (5)
where the asterisk indicates the presence of the macromolecule in solution.
The enhancement factor * is then related to the molar fraction () of the
bound paramagnetic metal complex:
* 
b	 1 1 (6)
where b is the enhancement factor of the all-bound Gd(III)L-Hb form. The
molar fraction () can be expressed in terms of the dissociation equilibrium
constant (KD) by
 
*	 1
b	 1

Hb	f
KD Hb	f
(7)
The subscript f indicates the free protein. More generally, the molar
fraction  depends on the total concentration of Hb, Gd(III)L, the number
of binding sites, and the constant KD. In the procedure, [Hb]f has been
calculated accordingly (Aime et al., 1996a).
If the protein is able to bind the paramagnetic complex at more than one
site, the KD value will be affected by the binding stoichiometry; it is then
necessary to determine independently the number of equivalent sites on the
protein. To this purpose, the protein is titrated with the complex and the
molar ratios obtained from the PRE data are reported under the form of a
Scatchard plot:
r
Gd(III)L	f

n
KD
	
r
KD
(8)
where r is the molar binding ratio of the protein (i.e., complex-ligated
protein over total protein), and it may easily be calculated once the
all-bound enhancement b is known:
r 
Gd(III)L	T
Hb	T
(9)
Gd(III)L	f 
1	 Gd(III)L	T (10)
In the same way, the free complex concentration is obtained from the
total complex concentration (Eq. 10). This gives a straight line with a
negative slope of KD
1 and an x axis intercept equal to n.
RESULTS
Fig. 1 reports the PRE factors * of solutions containing
0.10 mM Gd(III)L and variable amounts of HbA1c at pH 7.2
FIGURE 1 Water proton relaxation enhancement of a 0.10 mM Gd(III)L
solution at different oxygenated HbA1c concentration, at pH 7.2 and
25.0°C. Analysis of the data, according to the Proton Relaxation Enhance-
ment (PRE) procedure (see Eqs. 5–7), yields a KD value of 1.3  0.1 
105 M (b  2.2  0.1) for Gd(III)L binding to HbA1c.
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in PBS and 25.0°C. The analysis of the PRE curve, accord-
ing to the above theory, shows that the paramagnetic bo-
ronic probe Gd(III)L interacts with the syn-diol groups
present in oxygenated HbA1c with a KD value of 1.3 
0.1  105 M (by assuming a 1:1 stoichiometry). The
enhancement factor for this adduct (b) is 2.2  0.1, which
is slightly higher than the value found for the Gd(III)L-
human serum albumin adduct (b 1.5) at the same pH and
temperature (Aime et al., 1993a). It is likely that the binding
mode for Gd(III)L binding to glycated human serum albu-
min allows larger internal motions of the paramagnetic
moiety (glycation in albumin occurs on Lys side chains),
which results in a decrease in the effective dipolar correla-
tion time and, in turn, in the observed relaxivity (Lipari and
Szabo, 1982).
To determine the degree of glycation in an actual HbA
specimen, we needed to know the contribution to the water
relaxation rate arising from the interaction between the
Gd(III)L complex and oxygenated unglycated human he-
moglobin (HbA0), if any. Surprisingly, we found that
Gd(III)L binds to oxygenated HbA0 (KD  1.4  0.1 
105 M for an apparent 1:1 interaction; Fig. 2) as strongly
as to oxygenated HbA1c. Moreover, the resulting Gd(III)L-
HbA0 adduct displays a much higher enhancement factor
(b  7.1  0.2 at 25°C). The measurements of water
proton relaxation rates of solutions of Gd(III)L in the pres-
ence of different ratios of oxygenated HbA0/HbA1c showed
that the interaction with sugar residues precludes the inter-
action with the site on the protein, suggesting that the
binding site of Gd(III)L on oxygenated HbA0 should be in
the region where the glycation takes place. Indeed, the
presence of the glycidic residues results in a lower enhance-
ment of the solvent proton relaxation rate with respect to
solutions containing oxygenated HbA0 only. No relaxation
enhancement takes place in the presence of monomeric
hemoproteins such as horse myoglobin and horse heart
cytochrome c. This observation supports the view that the
interaction of Gd(III)L involves a site present in the tet-
ramer only.
The addition of sorbitol to a solution of Gd(III)L and
oxygenated HbA0 causes a marked decrease in the observed
relaxation rate. For a solution containing 1 mM HbA0 and
0.1 mM Gd(III)L, R1
obs decreases from 3.3 s1 to 0.6 s1
upon the addition of 20 mM sorbitol. This behavior may be
accounted for in terms of the competition between the
protein and sorbitol for the boronic functionalities on the
Gd(III)L complex. Moreover, in the presence of an even
larger excess of sorbitol, the measured relaxation rate is
further decreased to become similar to that of the free
complex (R1
obs  0.46 s1) indicating unambiguously that
the integrity of the Gd(III)L complex is maintained.
In a related experiment it has been found that the relax-
ation rate of a solution of Gd(III)L and oxy-HbA0 under-
goes a drastic change between pH 8.0 and 9.5 to reach, at
the basic limb, the same relaxation rate observed in the
absence of oxy-HbA0 (Fig. 3). Boronic esters are indeed
known to undergo hydrolysis at basic pH values; thus the
observed behavior simply reflects the release of the com-
plex from the adduct with the protein.
The assessment of the stoichiometry of the adduct was
gained by measuring the relaxation rate of solutions con-
taining a fixed concentration of HbO2 (0.2 mM as a tet-
ramer) with different Gd(III)L concentrations (up to 2
equivalents). Data are conveniently analyzed in the form of
a Scatchard plot according to Eq. 8. Fig. 4 clearly indicates
a 2:1 stoichiometry with HbO2; however, the slope of the
straight line affords a value of KD that does not match the
one calculated from the binding isotherm, even assuming a
2:1 stoichiometry. Data may be explained by considering a
two-site interaction, i.e., a high-affinity site that determines
the relaxation enhancement observed in Fig. 2, and a low-
affinity site whose KD value is calculated from Fig. 4.
Proton relaxation enhancement data have then been fitted
using the two-site model, affording refined values for KD of
1.0 0.1 105 M and 4.8 0.4 104 M, respectively.
Measurements performed at a low binding ratio (r  0.05–
0.15) with a higher protein concentration (0.4 mM) fit to the
straight line drawn using the KD value of 1.0  10
5 M, as
shown in the upper part of Fig. 4.
In the presence of inositol hexakisphosphate (IHP),
which is known to set up a strong heterotropic interaction
with the cavity where the natural allosteric effector 2,3-
FIGURE 2 Water proton relaxation enhancement of a 0.10 mM Gd(III)L
solution at different oxy-HbA0 (f) and deoxy-HbA0 () concentrations, at
pH 7.2 and 25.0°C.
FIGURE 3 Effect of the pH on the longitudinal relaxation rates (R1p) of
a solution containing 1.0 mM oxy-HbA0 and 0.1 mM Gd(III)L. Data were
obtained at 20 MHz and 25.0°C.
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diphosphoglycerate (DPG) binds to the tetramer, PRE data
are markedly affected. Fig. 5 shows a comparison between
Scatchard plots in the absence and in the presence of a
threefold excess of IHP. In the latter case, the slope indi-
cates a large KD over the whole r range, and the x axis
intercept cannot be determined accurately.
A titration of the Gd(III)L solution with the deoxygenated
HbA0 derivative (Fig. 2) was carried out at 20 MHz and
25.0°C. The analysis of the binding isotherm, using the
same asymptotic enhancement factor found for the
Gd(III)L-HbA0 adduct and assuming a 1:1 stoichiometry,
gives a KD value of 2.1  0.2  10
4 M for the interaction
of the paramagnetic adduct with deoxy-HbA0. The stoichi-
ometry is confirmed by the Scatchard plot reported in Fig.
4. The observed behavior indicates, therefore, that Gd(III)L
promotes a marked stabilization of the high-affinity versus
the low-affinity state of the tetramer. The stabilization of the
high-affinity form is further confirmed by the measurement
of R1p upon the addition of ferric (aquo-met) HbA to the
Gd(III)L solution. This Hb derivative shows an R-like con-
formation (Fermi and Perutz, 1981), and the measured re-
laxation enhancement curve (not shown) is similar to that of
oxy-HbA0 (KD  4.3  0.4  10
5 M, assuming n  1,
b  7.1  0.4).
According to the linked functions (Wyman, 1964; Anto-
nini and Brunori, 1971), the oxygen affinity for HbA0, in the
absence of Gd(III)L (P50  8  1 mm Hg; n  2.8  0.2),
is lower than that observed for the tetramer in the presence
of 1.0  104 M Gd(III)L (P50  1.0  0.3 mm Hg; n 
1.6  0.2) at pH 7.2 (PBS) and 25.0°C (Fig. 6).
The effect of Gd(III)L on the stabilization of the R state
of human hemoglobin is also supported by the measurement
of a 9% enhancement of the absorption spectra, in the Soret
region, of deoxy HbAo in the absence and presence of
Gd(III)L, at pH 7.2 (Fig. 7). The maximum at 430 nm (133
mM1 cm1) has been associated with the low-affinity T
state of the unligated tetramer (Antonini and Brunori, 1971).
The addition of Gd(III)L to deoxy HbAo in the absence of
atmospheric oxygen induces the transition to a species char-
acterized by a higher molar absorbance (145 mM1 cm1).
Such behavior has been attributed to the shift of the con-
formational equilibrium toward the R state with a conse-
quent strengthening of the proximal HisF8-Fe bond (Anto-
nini and Brunori, 1971).
Another proof of the switch of the quaternary conforma-
tion of the tetramer from the low-affinity to the high-affinity
form (i.e., from the T to the R state) comes from the
observation of the exchangeable 1H resonances of amino
acid residues located at the subunit interfaces of the Hb
tetramer (Russu et al., 1987). These residues are involved in
the hydrogen-bonding interactions that stabilize the quater-
nary structure, and their resonances are absent in the spectra
of isolated chains. On going from deoxy- to oxy-Hb, some
of these signals show significant variation in their chemical
shift, and two resonances almost disappear. These reso-
FIGURE 5 Scatchard plots for the binding interaction of Gd(III)L to 0.2
mM oxy-HbA0 in the absence (f) and in the presence () of 0.6 mM
inositol hexakisphosphate.
FIGURE 4 Scatchard plots for the binding interaction of Gd(III)L to
oxy-HbA0 (f) and deoxy-HbA0 (). Protein concentration is 0.4 mM for
the low binding ratio measurements on oxy-HbA0 (top of the graph) and
0.2 mM for all other measurements.
FIGURE 6 Hill plot for oxygen binding to HbA0 in the absence (E) and
in the presence (F) of 1.0 104 M Gd(III)L at pH 7.2 and 25.0°C. Values
of P50 and n are given in the text.
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nances are due to the intersubunit hydrogen bond between
Tyr42(1) and Asp
99(2) (14.1 ppm) and to the intrachain
hydrogen bond between Tyr145() and the Val98() car-
bonyl (11.1 ppm), an important feature in the deoxy tertiary
structure.
Fig. 8 shows the 1H-NMR spectra of deoxy-HbA0 in the
absence (trace A) and in the presence (trace B) of the
diamagnetic La(III)L. Trace C reports the spectral changes
upon the addition of La(III)L and IHP in a 1:1 ratio. The
disappearance of the signal at 14.1 ppm in trace B is
clear-cut evidence of the effect of La(III)L on the allosteric
equilibrium, resulting in the cleavage of the interdimer
hydrogen bond responsible for the stabilization of the T
state. This does not mean that an R state is reached; rather
the interchain interactions that keep the oxygen affinity low
are weakened, yielding a conformational state that resem-
bles the R state in the quaternary structure, conserving,
however, the features of a T state in the tertiary structures of
the globin chains (the shoulder at 11.1 ppm in all three
traces indicates that the globin conformation is that of the
unligated, deoxy form). Eventually, the simultaneous pres-
ence of La(III)L and IHP cancels this effect (trace C) and
restores the spectral pattern shown in trace A.
Under all of the experimental conditions, the possible
Ln(III)L-induced dissociation of HbA0 (even at the highest
Gd(III)L concentration used, 1.0  103 M) has been ruled
out on the basis of the values found for the sedimentation
coefficient (4.1  0.1) for the oxygenated, deoxygenated,
and ferric (aquo-met) derivatives of Hb, obtained in the
absence and in the presence of the metal complex. Values of
the sedimentation coefficient are indeed typical of the tet-
rameric state (Antonini and Brunori, 1971).
To better understand which amino acid residues could be
involved in this heterotropic interaction, we considered the
high-resolution 11B NMR spectra of the corresponding dia-
magnetic La(III)L complex (11B natural abundance 
81.17%, I  3/2). La(III)L at pH 7.4 shows a 11B resonance
at 30.7 ppm (W1/2  970 Hz), which moves upfield to 
 
7 ppm (W1/2 2300 Hz) in the presence of a fivefold excess
of oxy-HbA0. Upon recording the
11B-NMR spectrum of
La(III)L in the presence of amino acids like Arg, His, Lys,
or Ser, all potentially capable of forming a dative bond to
boron, we noted that, at pH 7.4, a marked upfield shift is
observed only in the presence of His (Fig. 9). The resulting
chemical shift (
  12 ppm when the His-to-La(III)L ratio
is 30:1) is close to the corresponding value found for the
adduct with oxy-HbA0. On the other hand, in the presence
of Arg, Lys, and Ser, the 11B chemical shift approaches the
value of the La(III)L-oxy-HbA0 adduct only at pH  9.
To gain more insight into the possible involvement of
histidines in the Gd(III)L binding to hemoglobin, we inves-
tigated the interaction of Gd(III)L with fetal hemoglobin
(HbF). In the quaternary structure of HbF, -chains are
replaced by -chains, where Ser is substituted for His143
(Antonini and Brunori, 1971). The binding isotherms for
FIGURE 8 1H-NMR (400 MHz) spectra of 0.5 mM deoxygenated HbA0
in 10%-deuterated PBS. Trace A: Resonances of exchangeable protons at
the intersubunit interface (assignments are given in the text). Trace B: After
the addition of 10 mM La(III)L. Trace C: After the addition of 10 mM
La(III)L and 10 mM IHP.
FIGURE 7 Absorption spectra, in the Soret region, of deoxygenated
HbA0 in the absence (trace A) and in the presence (trace B) of 4.0  10
3
M Gd(III)L. Spectra were recorded at pH 7.2 and 25°C, using a 1-cm path
length cuvette fitted with a two-hole screw cap for nitrogen flushing. HbA0
concentration was 1.73  106 M (expressed as tetramer).
FIGURE 9 Effect of pH on the 11B chemical shift (measured at 128 MHz
and 25.0°C) of 10.0 mM La(III)L interacting with Lewis-basic amino acids
(0.1 M) (, His; E, Ser; Œ, Lys; f, Arg). Shaded areas indicate the
chemical shifts of La(III)L complex in neat water and of the oxy-HbA0-
La(III)L adduct.
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Gd(III)L binding to oxy- and deoxy-HbF are reported in
Fig. 10. It is noticeable that the mutation His143Ser in the
DPG cavity implies a decrease in the asymptotic value
observed for oxy-HbF (b  5.1  0.3 versus 7.1  0.2 for
oxy-HbA0). A Scatchard plot has been drawn (not shown) to
determine the stoichiometry of the binding and the interac-
tion strength of the second molecule of Gd(III) binding to
the Hb tetramer (KD  5.4  0.7  10
4 M). By the use of
the two-site model described above, binding parameters for
the first molecule have been determined (KD 1.3 0.2
104 M, b 5.1 0.3). Gd(III)L binds to deoxy HbF with
an even higher dissociation constant (Fig. 10; KD  1.3 
0.5  103 M, b  5  1).
DISCUSSION
The complex Gd(III)L binds with very similar affinity to
human adult glycated and unglycated hemoglobins; how-
ever, the binding to HbA0 causes a sevenfold enhancement
of the solvent water proton relaxation rate, whereas in the
presence of HbA1c the enhancement is equal to 2.2. Thus
there are two different binding modes with very similar
strengths. Results obtained for mixtures of HbA0 and HbA1c
show that the glycation of Val1 residues of -chains pre-
cludes the kind of interaction that is observed when such
N-terminal residues are unligated. This observation sug-
gests that sugar residues in HbA1c act as gates over the
interaction site, thus providing an insight into the mode of
interaction of Gd(III)L on HbA0. In fact, the ends of
-chains where glycation takes place mark the boundaries
of the site of interaction for DPG, the well-known allosteric
effector that shifts the equilibrium toward the T state by
binding at the central cavity between the two -chains on
the twofold symmetry axis of the tetramer (Fermi and
Perutz; 1981). IHP binds much more strongly than DPG to
Hb at the same cleft (Fermi and Perutz, 1981).
The body of experimental results—values of the dissoci-
ation constants, the measurement of P50 in the presence of
Gd(III)L (Fig. 6), changes in the Soret band (Fig. 7) and in
the 1H-NMR spectra (Fig. 8)—clearly show that the com-
plex acts as an allosteric effector by stabilizing the high-
affinity form of HbA. The linked functions analysis (Eq. 11)
yields a P50 value in good agreement with that found
experimentally (Scheme 1):
log P50 log P50
o  0.25 log
1 KHbL	
1 KHbO2L	
(11)
These complexes have then to be included in the class of
allosteric effectors that increase the oxygen affinity of he-
moglobin (Abraham et al., 1995; Boyiri et al., 1995), al-
though their mode of action should be rather different from
that reported for bifunctional molecules able to link
-chains in a manner that constrains the tetramer in the R
state. One can envisage that IHP shifts the allosteric equi-
librium to the form that binds Gd(III)L less strongly, thus
acting in the same way as oxygen removal. Scatchard plots
reported here clearly show that IHP really competes with
Gd(III)L. Indeed, T-state (deoxy) HbA possess one site with
a KD value of 2.1  0.2  10
4 M, whereas IHP-saturated
HbA displays a much larger dissociation of the Gd(III)L-
HbA0 adduct. Thus Gd(III)L binding occurs in the same
region of DPG and IHP, although a quite different bonding
mode has to be adopted. The binding of Gd(III)L to HbA0
may be envisaged to occur through the coordination of
donor atoms of the protein to the Lewis acid boron centers
of the complex. The cleavage of the adduct occurs either by
the addition of sorbitol or by increasing pH. On the basis of
the results obtained by means of 11B-NMR spectroscopy
(Fig. 9), the anchoring sites for Gd(III)L on HbA0 deal with
histidine residues. (A number of attempts to prepare crystals
of the Ln(III)L-HbA0 adducts failed. Indeed, crystals of
oxygenated HbA0 cracked when they were soaked in a
Gd(III)L solution.) Actually, four His residues (His2 and
His143 of both -chains), together with Lys82 of both
-chains, define the binding site of DPG.
On going from the low-affinity to the high-affinity state
of Hb, the DPG cavity varies between an “open” and a
“closed” conformation (Fermi and Perutz, 1981). Clearly,
the stronger interaction shown by Ln(III)L complexes with
HbA0 in the R state suggests that it matches the “closed”
form better. In this conformation, His2 and His143 resi-
dues are no longer orientated toward the inside of the cavity,
as they are in the T conformation (Perutz et al., 1986). As
the HbA0 tetramer undergoes a rotation and translation of
the 11 dimer relative to the 22 dimer upon ligand
binding (Fermi and Perutz, 1981), His2 and His143 resi-
FIGURE 10 Water proton relaxation enhancement of a 0.10 mM
Gd(III)L solution at different oxy-HbF (f) and deoxy-HbF () concen-
trations, at pH 7.2 and 25.0°C. SCHEME 1
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dues move outward, becoming more suitable for binding to
the acceptor boron atoms provided by the Ln(III)L complex.
From the x-ray crystal structure of the oxygenated HbA
(Shaanan, 1983; PDB code  1HHO), it is possible to
determine the relative N-N distances inside the four pairs of
donor atoms formed by His2(1), His
2(2), His
143(1), and
His143(2) residues in the DPG pocket. An interchain link-
ing is necessary to justify the higher affinity for the R state,
as reported for the other class of effectors (Abraham et al.,
1995; Boyiri et al., 1995). Taking into account the steric
demand of Ln(III)L complexes and the different isomeric
structures they can adopt in water solutions (Aime et al.,
1995a), a potential binding site may be recognized in the
His2(1)-His
143(2) pair (and in the symmetry-equivalent
His2(2)-His
143(1) pair) (Scheme 2). Indeed, in each of
these pairs the interresidue N-N distance may become as
short as 10 Å, which fits quite well the boron-boron distance
(10 Å) evaluated with a model of Gd(III)L obtained by
using the structural data from the x-ray diffraction study of
the closely related bis(benzylamide)DTPA Gd(III) complex
(Aime et al., 1997). On this basis one may conclude that the
first molecule of Gd(III)L links the globin chains in the R
state by binding to one of the two (equivalent) His pairs at
the  interface. The second molecule is still able to rec-
ognize the linking site at the DPG cavity rim, but with a
lower affinity. Preliminary results on a related monoboronic
complex show a negligible interaction with HbA0, thus
underlining the structural requirement of this bifunctional
coordination compound.
On comparing the interaction of Gd(III)L with HbA0 and
HbF, the lack of His143 appears to be responsible for both
a weaker interaction and a smaller relaxation enhancement.
Asymptotic values (i.e., b in Eq. 6) are determined by a
number of factors, which are, in turn, dependent on the
structural determinants of the binding mode itself. The
observation of a smaller b in the case of the adduct with
fetal hemoglobin reflects a different structural arrangement
of the complex on the protein surface. The presence of
Ser143 might, of course, provide an alternative mode for
boronic acid coordination, as reported in the case of serine
enzymes, where Ser residues do form boronate esters (Aime
et al., 1996b).
Analysis of the dissociation constants of Gd(III)L with
HbF according to Eq. 11 provides an estimation of a de-
crease in the P50 of 1 mmHg (Scheme 3).
As a general remark, the results reported in this paper
show that metal complexes may provide a novel class of
allosteric effectors, thanks to their peculiar stereochemical
properties. Moreover, the spectroscopic properties of metal
complexes may be exploited to probe conformational vari-
ations of the protein structure and in turn act as reporters of
the physicochemical determinants of the protein conforma-
tions. A further peculiar feature of this class of compounds
is the fact that the binding isotherms are more easily ob-
tained by looking directly at the spectroscopic properties of
the effector itself rather than at the spectroscopic or func-
tional changes in the protein induced by the allosteric ef-
fector.
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